SCI Abstract

search
Disability inclusion in research and health care
Globally, one in six people have a disability, and individuals with disabilities often experience a narrow margin of healt...
A roadmap for clinical trials in MASH-related compensated cirrhosis
A roadmap for clinical trials in MASH-related compensated cirrhosis
Although metabolic dysfunction-associated steatohepatitis (MASH) is rapidly becoming a leading cause of cirrhosis worldwid...
Shifting targets for eosinophilic oesophagitis
Shifting targets for eosinophilic oesophagitis
Two phase III trials of new drugs for eosinophilic oesophagitis (EoE) have been reported in The New England Journal of Med...
Hepatitis E virus: from innate sensing to adaptive immune responses
Hepatitis E virus: from innate sensing to adaptive immune responses
Hepatitis E virus (HEV) infections are a major cause of acute viral hepatitis in humans worldwide. In immunocompetent indi...
Western lifestyle, metaflammation and the cell of origin of colon cancer
Western lifestyle, metaflammation and the cell of origin of colon cancer
Western lifestyles cause a low-grade but chronic and metabolic inflammation (or metaflammation), which might prime committ...
Mother-to-child transmission of hepatitis B: current status and the road forward
Mother-to-child transmission of hepatitis B virus remains a mode of transmission in high-burden regions where there are ga...
Viral hepatitis elimination — time to act
The countdown to the 2030 viral hepatitis elimination goal continues, but time is running out and progress is not keeping ...
Food inequity and insecurity and MASLD: burden, challenges, and interventions
Food inequity and insecurity and MASLD: burden, challenges, and interventions
Liver disease prevalence, severity, outcomes and hepatic risk factors (for example, unhealthy diet) are heavily affected b...
HCC genomic landscape in Chinese individuals
Researchers from the Chinese Liver Cancer Atlas project performed deep whole-genome sequencing of hepatocellular carcinoma...
Seladelpar in primary biliary cholangitis
In a phase III, double-blind, placebo-controlled trial, 193 patients with primary biliary cholangitis and an inadequate re...
Bacteriophages and host inflammation in IBD
Researchers analysed metagenomic data from 1,618 patients with inflammatory bowel disease (IBD) and 791 healthy individual...
Tackling sorbitol intolerance
Tackling sorbitol intolerance
Sorbitol, a poorly absorbable sweetener, is catabolized by gut microbiota, mainly Clostridia. Lee et al. now elucidate the...
New understanding of hepatobiliary MRI
New understanding of hepatobiliary MRI
Magnetic resonance imaging following injection of hepatobiliary contrast agents improves the detection of hepatocellular c...
Improving culturally safe engagement with sexual and gender minority populations
Cultural safety seeks to remediate health inequities through empowering marginalized and minoritized patient populations, ...
The changing metabolic landscape of bile acids – keys to metabolism and immune regulation
The changing metabolic landscape of bile acids – keys to metabolism and immune regulation
Bile acids regulate nutrient absorption and mitochondrial function, they establish and maintain gut microbial community co...
RET signalling controls gut motility
RET signalling controls gut motility
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obta...
New options for late-line treatment of metastatic colorectal cancer
New options for late-line treatment of metastatic colorectal cancer
Metastatic colorectal cancer is a heterogeneous disease associated with poor patient outcomes. Although the past ...
Gut microbiota in overweight and obesity: crosstalk with adipose tissue
Gut microbiota in overweight and obesity: crosstalk with adipose tissue
Overweight and obesity are characterized by excessive fat mass accumulation produced when energy intake exceeds energy exp...
Microbiota-based biomarkers and therapeutics for cancer management
Microbiota-based biomarkers and therapeutics for cancer management
New light is being shed on the interactions between the gut microbiome, cancer cell signalling and the host immune respons...
Tumour-associated macrophages and pancreatic cancer: an inflammatory loop
Tumour-associated macrophages and pancreatic cancer: an inflammatory loop
In a new study published in Nature, researchers have investigated the role of tumour-associated macrophages (TAMs) in panc...
Upgrading therapeutic ambitions and treatment outcomes
Upgrading therapeutic ambitions and treatment outcomes
Important studies published in 2023 outlined new agents and strategies for the management of inflammatory bowel disease. T...
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
Steatotic liver disease has emerged as an important risk factor for cardiovascular disease, type 2 diabetes mellitus and c...
Elafibranor in primary biliary cholangitis
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obta...
Resmetirom safe for nonalcoholic fatty liver disease
A 52-week randomized, double-blind, placebo-controlled phase III trial (MAESTRO-NAFLD-1) evaluated the safety of resmetiro...
See the reality again in the field of liver transplantation
In 2023, we witnessed advances in allocation policies and marginal donors, including living donors. Key improvements inclu...
Amitriptyline as second-line treatment for IBS in primary care settings
Titrated low-dose amitriptyline (a tricyclic antidepressant) was superior to placebo as a second-line treatment for irrita...
Fresh perspectives on how to build, maintain and repair the ENS
Fresh perspectives on how to build, maintain and repair the ENS
Enteric nervous system function is essential for survival. Studies published in 2023 have provided important novel insight...